Moneycontrol PRO
HomeNewsTrendsIndia’s largest COVID-19 facility in Delhi to have 10 times the capacity of China's biggest centre

India’s largest COVID-19 facility in Delhi to have 10 times the capacity of China's biggest centre

The deadline to make the first 2,000 of the 10,200 beds available at Delhi's new COVID-19 facility is June 25. The remaining beds are likely to be arranged by July 3

June 23, 2020 / 19:15 IST

India’s biggest COVID-19 facility, nearly ten times that of China’s Leishenshan facility, is set to open this week in South Delhi. It is as large as 15 football fields and can accommodate more than 10,000 coronavirus patients at a time, according to a Hindustan Times report.

“This would be 10 times bigger than the temporary field facility that was set up for novel coronavirus patients in China’s Leishenshan, which could accommodate 1,000 patients,” the report stated quoting a senior Home Ministry official.

The facility located in Chattarpur area will be run by medical personnel from the Indo-Tibetan Border Police (ITBP). It has been named the Sardar Patel COVID Care Centre and Hospital,

For live updates on coronavirus, click here

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The deadline to make the first 2,000 beds available at the COVID-19 facility is June 25, while the remaining beds will likely be arranged by July 3. Once all the 10,200 beds are operational, 800 general doctors would be required at the facility along with 70 specialist doctors and 1,400 nurses.

Earlier in June, when coronavirus cases in Delhi had begun increasing rapidly all of a sudden, the Home Minister had asked Lieutenant Governor Anil Baijal to urge the voluntary sector to help increase the national capital’s capacity to accommodate and treat COVID-19 cases. A spiritual organisation that had earlier helped migrants during the coronavirus lockdown period, was the first one to respond. They had told the government that they would be willing to provide meals to the coronavirus patients.

To follow our full coverage on coronavirus, click here

Moneycontrol News
first published: Jun 23, 2020 06:52 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347